Sabal yapa
Sabal yapa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Sabal yapa is a plant species that has gained scientific interest due to its potential therapeutic properties. Recent studies have focused on the antitumor activities associated with its medicinal components. Specifically, researchers have utilized extracts derived from the leaf to investigate biological impacts. The efficacy of these preparations is evaluated by measuring significant changes in tumor volume. Furthermore, the effectiveness of the treatment is also assessed through the analysis of total tumor weight.
- Synonyms
- Inodes Yapa · Sabal Peregrina · 2 more
- Common names
- Not available
- Family
- Arecaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Sabal yapa is a versatile palm known by a variety of distinct local names across different regions. Depending on the area, it is frequently referred to as Bay or Botan by those familiar with its growth. Some communities also use the terms Cana or Cana japa to identify this specific species. Additionally, the plant is recognized by the common name Chagareta in certain traditional contexts. These diverse naming conventions highlight the widespread cultural presence of this remarkable plant.
Sources: Catalogue of Life (COL)
Synonyms
Sabal yapa is a botanical species that has been classified under several different names throughout its taxonomic history. Scientific records indicate that it is recognized by the synonym Inodes yapa. Furthermore, researchers have previously identified this plant as Sabal mayara or Sabal peregrina. The species is also linked to the name Sabal yucatanica in various botanical contexts. Understanding these overlapping synonyms is essential for maintaining accurate botanical identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Sabal yapa is a remarkable specimen belonging to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. The plant further distinguishes itself as a member of the order Arecales. It falls specifically into the Arecaceae family, showcasing its connection to other palm species. Ultimately, this unique organism is identified by its specific genus, Sabal.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Arecales |
| Family | Arecaceae |
| Genus | Sabal |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Sabal yapa boasts an expansive geographic range that spans across several diverse regions. Its distribution begins in Northern America and extends through various parts of Mexico and Southeast Mexico. The plant's reach continues southward into the Caribbean, specifically including the island of Cuba. Furthermore, it is widely found throughout much of Southern America. This widespread presence also encompasses Central American territories such as Belize.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Sabal yapa is a self-supporting species characterized by its distinct tree-like growth form. This palm typically reaches a maximum height of 15 meters as it matures in its natural habitat. Its sturdy structure allows it to stand independently while reaching toward the canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Sabal yapa has demonstrated significant antitumor activity through the use of its sulfated polyphenol-rich leaf extract. In studies involving Ehrlich ascites carcinoma, the extract effectively reduced tumor volume and weight by substantial margins. This plant-based approach even surpassed the performance of the reference drug, 5-fluorouracil, in enhancing survival rates. Beyond its primary anticancer effects, the extract showed high safety levels and helped improve essential hematological parameters in treated subjects. These findings suggest that the flavonoids found within the plant could serve as a promising foundation for developing novel, low-side-effect cancer therapies.
Compounds
Sabal yapa is a remarkable plant species characterized by a high concentration of bioactive secondary metabolites. Research has specifically identified that its leaf extracts are rich in polyphenols, including various flavonoids and their sulfated derivatives. These chemical constituents provide the plant with substantial antioxidant properties and significant therapeutic potential. In experimental studies, these polyphenolic compounds demonstrated impressive antitumor activities by reducing tumor volume and increasing survival rates in models of Ehrlich ascites carcinoma. Consequently, the presence of these polyphenols makes Sabal yapa a promising candidate for the development of novel, safer anticancer medications.
Conditions
Sabal yapa exhibits significant antitumor activity by effectively treating Ehrlich ascites carcinoma. The plant extract demonstrates a powerful ability to reduce both tumor volume and tumor weight in treated subjects. Beyond its anticancer effects, it also helps manage liver health by treating elevated levels of ALT. Furthermore, the extract is capable of treating elevated levels of AST enzymes. These combined medicinal properties highlight the plant's potential as a therapeutic agent against cancer and associated physiological imbalances.
Preparations
Sabal yapa is prepared as an extract from its leaves to harness its rich concentration of sulfated polyphenols. This specific preparation is utilized to evaluate its potent antioxidant and anticancer properties against Ehrlich ascites carcinoma. Through the use of LC-MS/MS, researchers have successfully characterized the diverse secondary metabolites contained within this plant extract. The resulting substance has demonstrated the ability to significantly reduce tumor volume and increase survival rates in animal models. Consequently, this extract represents a promising candidate for the development of novel anticancer drugs with minimal side effects.
Parts used
Sabal yapa contains bioactive compounds that can be effectively harvested from its leaves. Researchers utilized LC-MS/MS to characterize the specific secondary metabolites found within this leaf extract. The study identified a rich variety of flavonoids and sulfated polyphenols that contribute to the plant's medicinal potential. These leaf-derived constituents demonstrated significant antioxidant and antitumor activities in experimental models. Ultimately, the leaf extract of Sabal yapa shows great promise as a natural foundation for developing safer anticancer therapies.